Screening of Korean Herbal Medicines with Inhibitory Activity on Advanced Glycation End Products Formation (XI) |
Choi, So Jin
(Korean Medicine-Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine)
Kim, Young Sook (Korean Medicine-Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine) Song, Yoo Jin (Korean Medicine-Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine) Kim, Joo Hwan (Department of Life Science, Gachon University) Kim, Jin Sook (Korean Medicine-Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine) |
1 | Sakurai, T. and Tsuchiya, S. (1988) Superoxide production from nonenzymatically glycated protein. FEBS Lett. 236: 406-410. DOI ScienceOn |
2 | Shinohara, R., Mano, T., Nagasaka, A., Sawai, Y., Uchimura, K., Hayashi, R., Hayakawa, N., Nagata, M., Makino, M., Kakizawa, H., Itoh, Y., Nakai, A. and Itoh, M. (1998) Effects of thyroid hormone on the sorbitol pathway in streptozotocininduced diabetic rats. Biochim. Biophys. Acta 1425: 577-586. DOI ScienceOn |
3 | Bucala, R., Cerami, A. and Vlassara, H. (1995) Advanced glycosylation end products in diabetic complications. Diabetes Rev. 3: 258-268. |
4 | Larkins, R. G. and Dunlop, M. E. (1992) The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35: 499-504. DOI ScienceOn |
5 | Ahmed, N. (2005) Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67: 3-21. DOI ScienceOn |
6 | Yokozaw, T., Nakagawa, T. and Terasawa, K. (2001) Effects of oriental medicines on the production of advanced glycation endproducts. J. Trad. Med. 18: 107-112. |
7 | Huebschmann, A. G., Vlassara, H., Regensteiner, J. G. and Reusch, J. (2006) Diabetes and advanced glycoxidation end products. Diabetes Care 29: 1420-1432. DOI ScienceOn |
8 | Rahbar, S. and Figarola, J. L. (2003) Novel inhibitors of advenced glycation endproducts. Arch. Biochem. Biophys. 419: 63-79. DOI ScienceOn |
9 | Wilkinson-Berka, J. L., Kelly, D. J., Koerner, S. M., Jaworski, K., Davis B., Thallas, V. and Cooper, M. E. (2002) ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2) 27 rat. Diabetes 51: 3283-3289. DOI ScienceOn |
10 | Peppa, M., Brem, H., Cai, W., Zhang, J. G., Basgen, J., Li, Z., Vlassara, H. and Uribarri, J. (2006) Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am. J. Nephrol. 26: 430-436. DOI ScienceOn |
11 | Yang, S., Litchfield, J. E. and Baynes, J. W. (2003) AGE breakers cleave model compounds, but do not break maillard crosslinks in skin and tail collagen from diabetic rats. Arch. Biochem. Biophys. 412: 42-46. DOI ScienceOn |
12 | Jang, D. S., Lee, Y. M., Kim, Y. S. and Kim, J. S. (2006) Screening of Korean traditional herbal medicines with inhibitory activity on advanced glycation end products (AGEs) formation. Kor. J. Pharmacogn. 37: 48-52. |
13 | Lee, Y. M., Kim, Y. S., Kim, J. M., Jang, D. S., Kim, J. W., Yoo, J. L. and Kim, J. S. (2008) Screening of Korean herbal medicines with inhibitory activity on advanced glycation end products (AGEs) formation (II). Kor. J. Pharmacogn. 39: 223-227. |
14 | Jeong, I. H., Kim, J. M., Jang, D. S., Kim, J. H., Cho, J. H. and Kim, J. S. (2009) Screening of Korean herbal medicines with inhibitory activity on advanced glycation end products (AGEs) formation (III). Kor. J. Pharmacogn. 40: 382-387. |
15 | Kim, J. M., Kim, Y. S., Kim, J. H., Yoo, J. M. amd Kim, J. S. (2009) Screening of herbal medicines from China and Vietnam with inhibitory activity on advanced glycation end products (AGEs) formation (IV). Kor. J. Pharmacogn. 40: 388-393. |
16 | Kim, Y. S., Choi, S. H. Kim, J. H. and Kim, J. S. (2011) Screening of herbal medicines from China with inhibitory activity on advanced glycation end products (AGEs) formation (V). Kor. J. Pharmacogn. 42: 46-53. |
17 | Lee, Y. M., Kim, Y. S., Kim, J. H. and Kim, J. S. (2011) Screening of herbal medicines from China with inhibitory activity on advanced glycation end products (AGEs) formation (VI). Kor. J. Pharmacogn. 42: 161-168. |
18 | Choi, S. J., Kim, Y. S., Song, Y. J., Lee, Y. M., Kim, J. H. and Kim J. S. (2012) Screening of Korean herbal medicines with inhibitory Activity on advanced glycation end products formation (VII). Kor. J. Pharmacogn. 43: 345-351. |
19 | Sohn, E. J., Kim, Y. S., Kim, C. S., Lee, Y. M. and Kim, J. S. (2009) KIOM-79 prevents apoptotic cell death and AGEs accumulation in retinas of diabetic db/db mice. J. Ethnopharmacol. 121: 171-174. DOI ScienceOn |
20 | Choi, S. J., Song, Y. J., Kim, Y. S., Kim, J. H., Hang, S., Bach, T.T. and Kim J. S. (2012) Screening of herbal medicines from China and Vietnam with inhibitory activity on advanced glycation end products (AGEs) formation (VIII). Kor. J. Pharmacogn.43: 338-344. |
21 | Kim, Y. S., Lee, Y. M., Kim, C. S., Sohn, E. J., Jang, D. S. and Kim, J. S. (2006) Inhibitory effect of KIOM-79, a new herbal prescription, on AGEs formation and expression of type IV collagen and TGF-in STZ-induced diabetic rats. Kor. J. Pharmacogn. 37: 103-109. |
22 | Kim, Y. S., Kim, J., Kim, C. S., Sohn, E. J., Lee, Y. M., Jeong, I. H., Kim, H., Jang, D. S. and Kim, J. S. (2009) KIOM-79, an inhibitor of AGEs-protein cross-linking, prevents progression of nephropathy in Zucker diabetic fatty rats. Evid. Based Complement. Alternat. Med. 2009 Jul 15. [Epub ahead of print] |
23 | Vinson, J.A., and Howard, III T.B. (1996) Inhibition of protein glycation and advanced glycation endproducts by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 7: 659-663. DOI ScienceOn |
24 | Strowig, S. and Raskin, P. (1992) Glycemic control and diabetic complications. Diabetes Care 15: 1126-1140. DOI ScienceOn |
25 | Yki-Jarvinen, H. (1990) Acute and chronic effects of hyperglycemia on glucose metabolism. Diabetologia 33: 579-585. DOI ScienceOn |
26 | Edelstein, D. and Brownlee, M. (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41: 26-29. |
27 | Soulis, T., Cooper, M. E., Bucala, R. and Jerums, G. (1996) Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int. 50: 627-634. DOI ScienceOn |
28 | Shin, T. Y., Shin, H. Y., Kim, S. H., Kim, D. K., Chae, B. S., Oh, C. H., Cho, M. G., Oh, S. H., Kim, J. H., Lee, T. K. and Park, J. S. (2006) Rubus coreanus unripe fruits inhibits immediate-type allergic reaction and inflammatory cytokine secretion. Nat. Prod. Sci. 12: 144-149. |
29 | Park, C. M., Jeong, M. S., Yang, D. Y. and Choi, J. W. (2007) The study on the effect of Rubus coreanus miquel extract as a cosmetic ingredient. J. Soc. Cosmet. Scientist. Korea. 33: 41-45. |
30 | Park, J. H., Oh, S. M., Lim, S. S., Lee, Y. S., Shin, H. K., Oh, Y. S., Choe, N. H., Park Yoon, J. H. and Kim J. K. (2006) Induction of heme oxygenase-1 mediates the anti-inflammatory effects of the ethanol extract of Rubus coreanus in murine macrophages. BBRC. 351: 146-152. |
31 | Jeon, Y. H., Choi, S. W. and Kim, M. R. (2009) Antimutagenic and cytotoxic activity of ethanol and water extracts from Rubus coreanum. Korean J. Food Cookey Sci. 25: 379-386. |
32 | Kim, K. H., Lee, Y. A., Kim, J. S., Lee, D. I., Choi, Y. W., Kim H. H. and Lee. M. W. (2000) Antioxidant activity of tannins from Rubus coreanus. Kor. J. Pharmacogn.44: 354-357. |
33 | Wu, M. J., Yen, J. H., Wang, L. and Weng, C. Y. (2004) Antioxidant activity of porcelainberry (Ampelopsis brevipedunculata( Maxim.) Trautv.). Am. J. Chin. Med. 32: 681-693. DOI ScienceOn |
34 | Rhim, T. J. and Choi, M. Y. (2010) The antioxidative effects of Ampelopsis brevipedunculata extracts. Korean. J. Plant. Res. 25: 445-450. |
35 | Yabe, N. and Matsui, H. (2000) Ampelopsis brevipedunculata (Vitaceae) extract inhibits a progression of carbon tetrachloride- induced hepatic injury in the mice. Phytomedicine. 7: 493-498. DOI ScienceOn |
36 | Choi, M. Y. and Rhim, T. J. (2010) Antimicrobal effect of Ampelopsis brevipedunculata extracts on food spoilage or foodhome disease microorganism. Korean. J. Plant. Res.23: 430-435. |
37 | Park, J. C. (2003) Inhibitory effects of Korean plant resources on human immunodeficiency virus type 1 protease activity. OPEM. 3: 1-7. |
38 | Wang, S. Y., Lan, X. Y., Xiao, J. H., Yang, J. C., Kao, Y. T. and Chang, S. T. (2008) Antiinflammatory activity of Lindera erythrocarpa fruits. Phytother. Res. 22: 213-216. DOI ScienceOn |
39 | Liu, S. Y., Hisada, S. and Inagaki, I. (1973) Terpenes of Lindera erythrocarpa. Phytother. Res.12: 233. |
40 | Choi, Y. H., Kwon, S. Y., Kim, J. H., Baek, N.I., Choi, G. J., Cho, K.Y. and Lee, B. M. (2003) Isolation of antifungal active compounds from the leaves of Lindera erythrocarpa. J. Korean Soc. Agric. Chem. Biotechnol. 46: 150-153. |
41 | Kim, J. A., Jung, Y. S., Kim, M. Y., Yang, S. Y., Lee, S. H. and Kim, Y. H. (2011) Protective effect of components isolated from Lindera erythrocarpa against oxidative stressinduced apoptosis of H9c2 cardiomyocytes. Phytother. Res. 25: 1612-1617. DOI ScienceOn |